Intact human ceruloplasmin oxidatively modifies low density lipoprotein.
Open Access
- 1 April 1994
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 93 (4), 1493-1501
- https://doi.org/10.1172/jci117127
Abstract
Ceruloplasmin is a plasma protein that carries most of the copper found in the blood. Although its elevation after inflammation and trauma has led to its classification as an acute phase protein, its physiological role is uncertain. A frequently reported activity of ceruloplasmin is its ability to suppress oxidation of lipids. In light of the intense recent interest in the oxidation of plasma LDL, we investigated the effects of ceruloplasmin on the oxidation of this lipoprotein. In contrast to our expectations, highly purified, undegraded human ceruloplasmin enhanced rather than suppressed copper ion-mediated oxidation of LDL. Ceruloplasmin increased the oxidative modification of LDL as measured by thiobarbituric acid-reacting substances by at least 25-fold in 20 h, and increased electrophoretic mobility, conjugated dienes, and total lipid peroxides. In contrast, ceruloplasmin that was degraded to a complex containing 115- and 19-kD fragments inhibited cupric ion oxidation of LDL, as did commercial preparations, which were also degraded. However, the antioxidant capability of degraded ceruloplasmin in this system was similar to that of other proteins, including albumin. The copper in ceruloplasmin responsible for oxidant activity was not removed by ultrafiltration, indicating a tight association. Treatment of ceruloplasmin with Chelex-100 removed one of seven copper atoms per molecule and completely blocked oxidant activity. Restoration of the copper to ceruloplasmin also restored oxidant activity. These data indicate that ceruloplasmin, depending on the integrity of its structure and its bound copper, can exert a potent oxidant rather than antioxidant action on LDL. Our results invite speculation that ceruloplasmin may be in part responsible for oxidation of LDL in blood or in the arterial wall and may thus have a physiological role that is quite distinct from what is commonly believed.This publication has 63 references indexed in Scilit:
- Inhibition by serum components of oxidation and collagen-binding of low-density lipoproteinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- Ceruloplasmin stimulates thymidine incorporation by CCL-39 cells in the absence of serum or growth factorsBiochemical and Biophysical Research Communications, 1991
- Immunological detection of low-density lipoproteins modified by malondialdehyde in vitro or in vivoBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
- Toxicity of oxidized low-density lipoprotein to cultured fibroblasts is selective for S phase of the cell cycleJournal of Cellular Physiology, 1987
- Inhibition of the Fenton reaction by the protein caeruloplasmin and other copper complexes. Assessment of ferroxidase and radical scavenging activitiesChemico-Biological Interactions, 1985
- The role of liver endothelium in the binding and uptake of ceruloplasmin: Studies with colloidal gold probeJournal of Ultrastructure Research, 1985
- Inhibition by the protein ceruloplasmin of lipid peroxidation stimulated by an Fe3+ -ADP-adriamycin complexFEBS Letters, 1984
- Antioxidant properties of caeruloplasmin towards iron‐ and copper‐dependent oxygen radical formationFEBS Letters, 1983
- Antioxidant effect of caeruloplasmin on microsomal lipid peroxidationFEBS Letters, 1983
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970